Variant report
Variant | nsv890892 |
---|---|
Chromosome Location | chr8:51846792-51946827 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:109)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF2 | chr8:51934062-51934395 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr8:51934115-51934341 | GM12878 | blood: | n/a | chr8:51934250-51934261 |
3 | BATF | chr8:51934082-51934330 | GM12878 | blood: | n/a | chr8:51934250-51934261 |
4 | BCL11A | chr8:51934103-51934327 | GM12878 | blood: | n/a | n/a |
5 | CEBPB | chr8:51853747-51854039 | IMR90 | lung: | n/a | n/a |
6 | CEBPB | chr8:51853777-51854033 | A549 | lung: | n/a | n/a |
7 | CEBPB | chr8:51943286-51943588 | HepG2 | liver: | n/a | n/a |
8 | CEBPB | chr8:51853745-51854060 | H1-hESC | embryonic stem cell: | n/a | n/a |
9 | CEBPB | chr8:51943318-51943587 | IMR90 | lung: | n/a | n/a |
10 | CTCF | chr8:51856872-51856953 | LNCaP | prostate: | n/a | n/a |
11 | CTCF | chr8:51856980-51857130 | MCF-7 | breast: | n/a | n/a |
12 | CTCF | chr8:51885340-51885490 | Caco-2 | colon: | n/a | n/a |
13 | CTCF | chr8:51860171-51860176 | LNCaP | prostate: | n/a | n/a |
14 | CTCF | chr8:51901176-51901215 | GM20000 | blood: | n/a | n/a |
15 | CTCF | chr8:51913389-51913420 | GM10266 | blood: | n/a | n/a |
16 | CTCF | chr8:51856871-51856889 | MCF-7 | breast: | n/a | n/a |
17 | CTCF | chr8:51865763-51865828 | GM10266 | blood: | n/a | n/a |
18 | CTCF | chr8:51940220-51940245 | Lung_OC | lung: | n/a | n/a |
19 | CTCF | chr8:51856671-51856989 | T-47D | breast: | n/a | n/a |
20 | E2F4 | chr8:51937201-51937571 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | E2F4 | chr8:51895598-51895784 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | E2F4 | chr8:51919099-51919441 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | E2F4 | chr8:51893910-51894441 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | E2F4 | chr8:51918023-51918214 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | EBF1 | chr8:51932957-51933099 | GM12878 | blood: | n/a | n/a |
26 | EBF1 | chr8:51933670-51934344 | GM12878 | blood: | n/a | n/a |
27 | EP300 | chr8:51934100-51934384 | GM12878 | blood: | n/a | n/a |
28 | EP300 | chr8:51933587-51933907 | GM12878 | blood: | n/a | n/a |
29 | EP300 | chr8:51934134-51934362 | GM12878 | blood: | n/a | n/a |
30 | FAM48A | chr8:51879216-51879319 | GM12878 | blood: | n/a | n/a |
31 | FOS | chr8:51891261-51891401 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | FOXM1 | chr8:51934060-51934449 | GM12878 | blood: | n/a | n/a |
33 | GATA3 | chr8:51944746-51945116 | MCF-7 | breast: | n/a | n/a |
34 | GATA3 | chr8:51894177-51894271 | SH-SY5Y | brain: | n/a | n/a |
35 | IKZF1 | chr8:51933649-51934270 | GM12878 | blood: | n/a | n/a |
36 | JUN | chr8:51939861-51940026 | K562 | blood: | n/a | n/a |
37 | MAFF | chr8:51847802-51847895 | HepG2 | liver: | n/a | n/a |
38 | MAFF | chr8:51934142-51934370 | HepG2 | liver: | n/a | n/a |
39 | MAFK | chr8:51926513-51926537 | K562 | blood: | n/a | n/a |
40 | MAFK | chr8:51934148-51934405 | HepG2 | liver: | n/a | chr8:51934253-51934268 |
41 | MAFK | chr8:51934096-51934318 | H1-hESC | embryonic stem cell: | n/a | chr8:51934253-51934268 |
42 | MAFK | chr8:51905888-51906021 | H1-hESC | embryonic stem cell: | n/a | n/a |
43 | MAFK | chr8:51934155-51934370 | HepG2 | liver: | n/a | chr8:51934253-51934268 |
44 | MAZ | chr8:51896730-51896733 | HepG2 | liver: | n/a | n/a |
45 | MAZ | chr8:51853064-51853065 | HepG2 | liver: | n/a | n/a |
46 | MAZ | chr8:51848045-51848060 | HepG2 | liver: | n/a | n/a |
47 | MXI1 | chr8:51934211-51934263 | GM12878 | blood: | n/a | n/a |
48 | MYC | chr8:51904785-51904938 | H1-hESC | embryonic stem cell: | n/a | n/a |
49 | MYC | chr8:51933173-51933533 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | MYC | chr8:51904905-51904933 | GM12878 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000201316 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538472673 | chr8:51846843-51846844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558690212 | chr8:51846845-51846846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs193113856 | chr8:51846859-51846860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377148304 | chr8:51846863-51846864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs553159487 | chr8:51846879-51846880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575614156 | chr8:51846901-51846902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146400759 | chr8:51846906-51846907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373691685 | chr8:51846910-51846911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555070004 | chr8:51846927-51846928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs184406023 | chr8:51846951-51846952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs115611568 | chr8:51846967-51846968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189278341 | chr8:51846973-51846974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139748821 | chr8:51846982-51846983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544507992 | chr8:51847036-51847037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577942960 | chr8:51847066-51847067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs118055795 | chr8:51847111-51847112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574463028 | chr8:51847156-51847157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs7829558 | chr8:51847173-51847174 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs192946743 | chr8:51857010-51857011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184476202 | chr8:51857022-51857023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576811486 | chr8:51857030-51857031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543872729 | chr8:51857070-51857071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554649901 | chr8:51857071-51857072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73576100 | chr8:51857076-51857077 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs73576101 | chr8:51857088-51857089 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs189176997 | chr8:51857177-51857178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559949884 | chr8:51857178-51857179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528544419 | chr8:51857188-51857189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555424344 | chr8:51857190-51857191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571544150 | chr8:51857214-51857215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532498306 | chr8:51857217-51857218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73578005 | chr8:51857296-51857297 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs569508757 | chr8:51857313-51857314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs370806370 | chr8:51857315-51857316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555177212 | chr8:51857363-51857364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114439138 | chr8:51857365-51857366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142758144 | chr8:51857373-51857374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs79448196 | chr8:51857389-51857390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576867187 | chr8:51857444-51857445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201160253 | chr8:51857446-51857447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs147376587 | chr8:51857450-51857451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs181911624 | chr8:51857499-51857500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574376027 | chr8:51857521-51857522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs578202595 | chr8:51857538-51857539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs541750767 | chr8:51857554-51857555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374580520 | chr8:51857571-51857572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs578253849 | chr8:51857590-51857591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544116839 | chr8:51857595-51857596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559914754 | chr8:51857598-51857599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs527525058 | chr8:51857614-51857615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
22q11 deletion syndrome | 20357662 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:51846800-51847200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr8:51857000-51859400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr8:51885000-51885400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr8:51885200-51886000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr8:51897800-51899000 | Enhancers | Dnd41 | blood |
6 | chr8:51932000-51932200 | Active TSS | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr8:51933200-51933400 | Active TSS | GM12878-XiMat | blood |
8 | chr8:51933400-51933600 | Flanking Active TSS | GM12878-XiMat | blood |
9 | chr8:51933600-51933800 | ZNF genes & repeats | GM12878-XiMat | blood |
10 | chr8:51933600-51934200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
11 | chr8:51933800-51934000 | Flanking Active TSS | GM12878-XiMat | blood |
12 | chr8:51944600-51945000 | Enhancers | Adipose Nuclei | Adipose |